Anticancer drugs may hold promise for premature aging disorder
Brian Capell and his colleagues at the National Human Genome Research Institute (NHGRI) reported that drugs known as farnesyltransferase inhibitors (FTIs), which are currently being tested in people
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.